Dental researchers discover human beta defensins-3 ignite in oral cancer growth

Jul 13, 2010

Detecting oral cancer in its earliest stages can save the lives of the nearly 40,500 people diagnosed annually. But early detection has been difficult.

Case Western Reserve University School of researchers discovered a biomarker, called human beta defensin-3 (hBD-3), which may serve as an early warning. The defensin is present in all oral cancers and associated with the early stages of oral cancer.

"Using the biomarker to detect oral cancer holds potential for saving lives when the cancer is most curable. Annually some 10,000 people die from this cancer," said Ge Jin, assistant professor of biological sciences at the dental school.

He led the study, "An Antimicrobial Peptide Regulates Tumor-Associated Macrophage Trafficking via the Chemokine Receptor CCR2, a Model for Tumorigenesis." The Public Library of Science published the research in .

Oral cancer first appears as white or red in the mouth, the same as noncancerous lesions.

Often, the lesions are not biopsied, and cancer is not discovered until it becomes apparent in its later stages, when it has metastasized to other organs. Such a late-stage diagnosis is generally fatal and can result in costly surgeries and treatments or disfigurement that may include removing parts of the tongue, jaw and cheek. All this can be avoided with early removal of the lesion.

The hBD-3 biomarker is one of many innate immune peptides found in the epithelial lining of the mouth. In a normal, healthy oral cavity, hBD-1, -2 and -3 ward off the hundreds of bacteria that constantly challenge the human immune system in the mouth.

While hBD-1 and -2 are on the frontline defense, hBD-3 is only found in the basal layer where oral cancers grow. The researchers report that the hBD-2 disappears and only hBD3 is present when a progresses.

Jin added that the lone presence of hBD-3 made the research team question its role on tumor growth and found it attracts other molecules that actually help the cancerous tumor grow and eventually spread to other parts of the body.

It appears hBD-3 plays a role in the development of the chemokine receptor called CCR2 that recruits tumor-associated macrophage cells to infiltrate the tumor site and stimulate . The tumor-associated macrophages and other molecules release growth factors that encourage the progression of the tumor. Eventually tumor cells break away, travel and spread the cancer to other places in the body.

"This is the first time that we have evidence that CCR2, too, has a role in growth," said Jin.

The researcher plans to continue studying the role of hBDs in oral health and to develop diagnostic tools that use the biomarker to detect early cancer.

Explore further: Brain tumor causes and risk factors elude scientists

add to favorites email to friend print save as pdf

Related Stories

Oral cancer patients could be diagnosed earlier

Dec 10, 2008

Worldwide, more than 500,000 new cases of cancer of the mouth are diagnosed each year. The majority of these cancers are found too late, causing many people to die within five years of finding out they have cancer. There ...

Absence of CLP protein can be indicative of oral cancer

Jan 07, 2009

Human calmodulin-like protein (CLP) is found in many cell types including breast, thyroid, prostate, kidney, and skin. The protein can regulate many cell activities and has a highly specific expression. Gaining an understanding ...

Dentists need more training in oral cancer detection

May 29, 2007

More than 92 percent of Illinois dentists provide oral cancer examinations for their patients, but many are not performing the procedures thoroughly or at optimum intervals, according to a new University of Illinois at Chicago ...

Recommended for you

Study shows epigenetic changes can drive cancer

4 hours ago

Cancer has long been thought to be primarily a genetic disease, but in recent decades scientists have come to believe that epigenetic changes – which don't change the DNA sequence but how it is 'read' – also play a role ...

Clearing cells to prevent cervical cancer

19 hours ago

A study published online in the International Journal of Cancer earlier this month describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk of cervical cancer after ...

User comments : 0